Left occipital high-grade glioma





Introduction


An uncommon location for gliomas is the occipital lobe, in which the incidence ranges from 5% to 10% in several series. Patients with occipital lobe gliomas typically present with seizures but can have more subtle deficits in visual fields and neurocognitive function, including attention, proprioception, reading, and writing. , Moreover, dominant hemisphere lesions can be in close juxtaposition to language-associated white matter tracts, in which surgery can be associated with significant morbidity. , In this chapter, we present a case of a dominant hemisphere occipital high-grade glioma.



Example case


Chief complaint: right-sided vision loss and difficulty speaking


History of present illness


A 73-year-old, right-handed woman with a history of hypertension, hypercholesterolemia, and asthma presented with progressive right-sided vision loss and difficulty speaking. She was seen by her primary care physician when she stated she noticed having a blind spot on the right side when she was at a four-way intersection. In addition, she complains of difficulty with word pronunciation ( Fig. 25.1 ).




  • Medications : Lisinopril, fluticasone, simvastatin.



  • Allergies : No known drug allergies.



  • Past medical and surgical history : Hypertension, hypercholesterolemia, asthma, right knee replacement.



  • Family history : No history of intracranial malignancies.



  • Social history : Retired teacher, no smoking, social alcohol.



  • Physical examination : Awake, alert, oriented to person, place, and time; Language: intact naming and repetition but with slight dysarthria; Cranial nerves II to XII intact except right homonymous hemianopsia; No drift, moves all extremities with full strength.



  • Imaging : Chest/abdomen/pelvis with no evidence of primary disease.




Fig 25.1


Preoperative magnetic resonance imaging. (A) T1 axial image with gadolinium contrast; (B) T1 coronal image with gadolinium contrast; (C) T1 sagittal with gadolinium contrast magnetic resonance imaging scan demonstrating a contrast-enhancing lesion involving the left occipital lobe.








































































































































































Bob S. Carter, MD, PhD, Massachusetts General Hospital, Boston, MA, United States Sunit Das, MD, PhD, St. Michael’s Hospital, University of Toronto, Toronto, Canada Maciej S. Lesniak, MD, Northwestern University, Chicago, IL, United States Jinsong Wu, MD, PhD, Fudan University, Huashan Hospital, Shanghai, China
Preoperative
Additional tests requested None Visual field testing Visual field testing Tasked-based BOLD
DTI
MRS
PWI
Neuropsychological assessment
Surgical approach selected Left occipital craniotomy with 5-ALA Left temporo-occipital craniotomy Left occipital craniotomy Left parietal needle biopsy (because of age)
Anatomic corridor Occipital-parietal Occipital–lingual gyrus Occipital Angular gyrus, IPL
Goal of surgery Diagnosis, debulking Resection of contrast-enhancing portion Resection of contrast-enhancing portion Diagnosis
Perioperative
Positioning Left lateral Left lateral Left park bench Prone with 30-degree left rotation
Surgical equipment Surgical navigation
Surgical microscope with 5-ALA
Ultrasonic aspirator
Surgical navigation
Ultrasound
Surgical microscope
Ultrasonic aspirator
Surgical navigation
Surgical microscope
Surgical navigation
Needle biopsy kit
Medications 5-ALA
Mannitol, furosemide
Antiepileptics
Steroids Mannitol
Steroids
Steroids
Antiepileptics
Anatomic considerations Posterior corpus callosum Visual pathways, corpus callosum, ventricle Motor and visual cortex, visual fields Angular gyrus, STG/MTG, optic radiations, IFOF, splenium, major forceps of corpus callosum, precuneus, cuneus, parieto-occipital sulcus
Complications feared with approach chosen Speech deficits Visual deficit Visual and motor deficit Hemorrhage
Intraoperative
Anesthesia General General General General
Skin incision U-shaped Horseshoe Linear Linear
Bone opening Left parieto-occipital Left temporo-occipital Left occipital Left parietal (burr hole)
Brain exposure Left parieto-occipital Left temporo-occipital Left occipital Angular gyrus
Method of resection Craniotomy based on navigation, dural opening, trans parieto-occipital based on navigation using shortest distance, internal debulking, resect residual with 5-ALA, anticipate residual anteriorly near corpus callosum Craniotomy based on navigation, flap designed based on axial planes, ultrasound to visualize most superficial portion of tumor to cortical surface, dural opening, corticectomy based on ultrasound, surgical microscope to dissect through white matter, internal debulking and working to the edges using ultrasound and microscope, dural tack up sutures Craniotomy based on navigation, determine shortest distance based on navigation, internal debulking under microscopic visualization, minimize retraction, resection of enhancing portion Trajectory based on navigation, burr hole, dural opening over angular gyrus, targeting three sites within lesion, four samples from each target point
Complication avoidance Internal debulking, 5-ALA, anticipate anterior residual Internal debulking Internal debulking Angular gyrus starting point, needle biopsy
Postoperative
Admission ICU ICU ICU ICU
Postoperative complications feared Expect visual deficit, speech deficit Visual deficit, CSF leak Visual deficit, seizure Hemorrhage
Follow-up testing MRI within 48 hours after surgery MRI within 48 hours after surgery CT within 12 hours after surgery
MRI within 48 hours after surgery
CT head immediately after surgery
Follow-up visits 7–10 days after surgery 1 month after surgery 14 days after surgery 1 month after surgery
Adjuvant therapies recommended
IDH status Mutant–radiation/temozolomide
Wild type–radiation/temozolomide
Mutant–radiation/temozolomide
Wild type–radiation/temozolomide
Mutant–radiation/temozolomide + TTF
Wild type–radiation/temozolomide + TTF
Mutant–radiation/ temozolomide
Wild type–radiation/temozolomide
MGMT status Methylated–radiation/temozolomide
Unmethylated–radiation/temozolomide
Methylated–radiation/temozolomide
Unmethylated–radiation/temozolomide
Methylated–radiation/temozolomide + TTF
Unmethylated–radiation/temozolomide + TTF
Methylated–temozolomide
Unmethylated–radiation/ temozolomide

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 15, 2025 | Posted by in NEUROSURGERY | Comments Off on Left occipital high-grade glioma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access